Biomerica Inc

BMRA05 Dec 2024
Healthcare
$0.36
-0.06 (-6.23%)
Lowest Today
$0.34
Highest Today
$0.39
Today’s Open
$0.36
Prev. Close
$0.4
52 Week High
$2.13
52 Week Low
$0.24
To Invest in Biomerica Inc

Biomerica Inc

Healthcare
BMRA05 Dec 2024
-0.06 (-6.23%)
1M
3M
6M
1Y
5Y
Low
$0.34
Day’s Range
High
$0.39
0.34
52 Week Low
$0.24
52-Week Range
52 Week High
$2.13
0.24
1 Day
-
1 Week
-1.26%
1 month return
+13.37%
3 month return
-2.5%
6 month return
-30.35%
1 Year return
-59.37%
3 Years return
-90.73%
5 Years return
-85.92%
10 Years return
-
Institutional Holdings
Granahan Investment Management Inc..
3.14
Acadian Asset Management LLC
1.34
JNL Multi-Manager Small Cap Growth A
1.26
Vanguard Group Inc
1
Vanguard Institutional Extnd Mkt Idx Tr
1
BlackRock Inc
0.89
Russell Inv Small Cap Fund B
0.76
Fundamentals
Market Cap
5.46 mln
PB Ratio
1.25
PE Ratio
0
Enterprise Value
4.81 mln
Total Assets
9.25 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California.
Organisation
Biomerica Inc
Employees
64
Industry
Medical Devices
CEO
Mr. Zackary S. Irani
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities